Literature DB >> 23732459

Dialysis: Heparin-free haemodialysis--use and outcomes.

Beata Naumnik1, Michał Myśliwiec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23732459     DOI： 10.1038/nrneph.2013.106

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

Review 1.  Unfractionated heparin for hemodialysis: still the best option.

Authors:  Robert E Cronin; Robert F Reilly
Journal:  Semin Dial       Date:  2010 Sep-Oct       Impact factor: 3.455

2.  Spanish study of anticoagulation in haemodialysis.

Authors:  José A Herrero-Calvo; Emilio González-Parra; Rafael Pérez-García; Fernando Tornero-Molina
Journal:  Nefrologia       Date:  2012-01-27       Impact factor: 2.033

Review 3.  What are the anticoagulation options for intermittent hemodialysis?

Authors:  Andrew Davenport
Journal:  Nat Rev Nephrol       Date:  2011-07-05       Impact factor: 28.314

4.  Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.

Authors:  Corrado Vitale; Silvia Berutti; Cristiana Bagnis; Giorgio Soragna; Paolo Gabella; Claudia Fruttero; Martino Marangella
Journal:  J Nephrol       Date:  2013 Jan-Feb       Impact factor: 3.902

5.  Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.

Authors:  Solbjørg Sagedal; Anders Hartmann; Kåre Osnes; Stine Bjørnsen; Josephine Torremocha; Per Fauchald; Johan Kofstad; Frank Brosstad
Journal:  Nephrol Dial Transplant       Date:  2005-10-18       Impact factor: 5.992

6.  Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study.

Authors:  Michèle Kessler; Concetta Gangemi; Alberto Gutierrez Martones; Jean-Louis Lacombe; Marie-Jeanne Krier-Coudert; Roula Galland; Jan T Kielstein; Frédérique Moureau; Nathalie Loughraieb
Journal:  Hemodial Int       Date:  2012-08-23       Impact factor: 1.812

7.  Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II.

Authors:  Jacek Borawski; Edyta Zbroch; Alicja Rydzewska-Rosolowska; Krystyna Pawlak; Michal Mysliwiec
Journal:  J Nephrol       Date:  2007 May-Jun       Impact factor: 3.902

8.  Use and safety of heparin-free maintenance hemodialysis in the USA.

Authors:  Jenny I Shen; Aya A Mitani; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2013-04-05       Impact factor: 5.992
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.